Ilaria Parisi
Head Of Technology Transfer Large Molecules BSP Pharmaceuticals
Seminars
Wednesday 5th November 2025
Improving ADC Quality & Manufacturing While Cutting Program Costs to Accelerate ADC Accessibility to Patients
9:30 am
- Advancing ADC development through cost-effective solutions to make ADC’s benefit versus standard of care more pronounced
- Driving ADC success with flexible and high-quality solutions from preclinical development to long-term commercial supply
- Ensuring right first-time-approved regulatory submission to save time and costs bringing ADCs to patients in need
